Dr. Allan Pamba
Global Health Consultant
Dr Pamba is an Independent Global Health Consultant. He has been CEO of the Nairobi Hospital where he initiated and oversaw construction of a 100Bed state of the art COVID hospital. This was an innovative partnership venture with the United nations. He built his career in the Pharmaceutical sector. As GlaxoSmithkline’s (GSK) VP, Pharmaceuticals, East Africa and Government Affairs, Africa, he was responsible for commercial operations in 9 Eastern Africa countries. In this role he drove sustainable delivery of medicines & vaccines via innovative business models. He also directed GSK’s engagement with Governments & other Global Health stakeholders in Africa, leading to many successful partnerships towards Healthcare Access.
Dr Pamba has been Co-Chair of the UN, Every Woman Every Child Innovation Working Group (IWG), a role he shared with Dr Peter Singer -currently a special advisor to the WHO DG, Dr Tedros Adhenom. The Innovation Working Group (IWG) was created in 2010 to unlock innovations that can accelerate progress towards the health MDGs, in support of the Global Strategy for Women’s and Children’s Health. It was part of the UN Secretary General’s Every Woman Every Child Initiative (EWEC).
Prior to GSK, Dr Pamba trained & worked as a physician in Kenya. He worked in clinical care at various levels at Government facilities, rural mission hospitals & research hospitals. He conducted clinical trials on management of severe Malaria in children at the Wellcome-Trust Research Unit in Kilifi Kenya and has published several papers on malaria. Dr Pamba set up one of the first HIV Comprehensive Care Clinics in government service in Kenya benefitting from PEPFAR funding. He has a special interest in equitable access to healthcare & over-all economic & social development in developing countries across Africa & Asia.